Pain News and Research

Latest Pain News and Research

Daratumumab achieves 29.2% overall response rate in heavily pre-treated patients with multiple myeloma

Daratumumab achieves 29.2% overall response rate in heavily pre-treated patients with multiple myeloma

BioDelivery Sciences calls for new treatment options for opioid addiction

BioDelivery Sciences calls for new treatment options for opioid addiction

2015 EuroHeartCare annual meeting to highlight recent advances in cardiovascular nursing research, practice

2015 EuroHeartCare annual meeting to highlight recent advances in cardiovascular nursing research, practice

Tennessee physician offers innovative painless procedure for postmenopausal patients

Tennessee physician offers innovative painless procedure for postmenopausal patients

Acupuncture-like TENS may be effective for treating radiation-induced xerostomia

Acupuncture-like TENS may be effective for treating radiation-induced xerostomia

Fair Rate Funding: Delaware woman gets $100M against Boston Scientific in TV mesh judgment

Fair Rate Funding: Delaware woman gets $100M against Boston Scientific in TV mesh judgment

People with cognitive impairment have altered responses to pain

People with cognitive impairment have altered responses to pain

Eli Lilly to present Phase III PROCLAIM trial results at ASCO Annual Meeting

Eli Lilly to present Phase III PROCLAIM trial results at ASCO Annual Meeting

New clinical data demonstrating treatment options in Lilly's diabetes portfolio to be presented at ADA Scientific Sessions

New clinical data demonstrating treatment options in Lilly's diabetes portfolio to be presented at ADA Scientific Sessions

First European approval of drug to treat genetic kidney disease ADPKD

First European approval of drug to treat genetic kidney disease ADPKD

DDW 2015: Experts explore efficacy of Stretta therapy for treating chronic GERD patients

DDW 2015: Experts explore efficacy of Stretta therapy for treating chronic GERD patients

New TB-Profiler tool to find appropriate drugs for TB patients may improve likelihood of cure

New TB-Profiler tool to find appropriate drugs for TB patients may improve likelihood of cure

Neurosurgeon performs first endoscopic removal of spinal tumor at Rhode Island Hospital

Neurosurgeon performs first endoscopic removal of spinal tumor at Rhode Island Hospital

Lilly Diabetes Alliance, Boehringer Ingelheim to present study results at ADA’s Scientific Sessions

Lilly Diabetes Alliance, Boehringer Ingelheim to present study results at ADA’s Scientific Sessions

Study shows differences in rates of paracetamol-linked acute liver failure among European countries

Study shows differences in rates of paracetamol-linked acute liver failure among European countries

ESSA Pharma reports net loss of $5.9 million for second quarter 2015

ESSA Pharma reports net loss of $5.9 million for second quarter 2015

Janssen, Bayer HealthCare initiate CALLISTO program to study rivaroxaban in patients with active cancer

Janssen, Bayer HealthCare initiate CALLISTO program to study rivaroxaban in patients with active cancer

Novel survey shows high rates of tattoo-related infection, itching and swelling in New Yorkers

Novel survey shows high rates of tattoo-related infection, itching and swelling in New Yorkers

Charcot foot increasing among diabetics

Charcot foot increasing among diabetics

Study shows how people's expectation of pain affects the experience of pain

Study shows how people's expectation of pain affects the experience of pain

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.